Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rLH Supplementation in IVF with Excessive LH Suppression
NCT07128394Recruiting
- Sponsor
- Nanjing University
- Start
- Feb 2024
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of lutropin alfa in infertility (2 arms), sponsored by Nanjing University. Primary endpoint: Proportion of cycles with no usable embryos. Started Feb 2024; status: recruiting.
02
Drugs
lutropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT07128394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07128394.